174 related articles for article (PubMed ID: 35272892)
1. Value of Assessment of Different Neoplasias in the Adnexa in the Differential Diagnosis of Malignant Ovarian Tumor and Benign Ovarian Tumor: A Meta-analysis.
Yue X; Zhong L; Wang Y; Zhang C; Chen X; Wang S; Hu J; Hu J; Wang C; Liu X
Ultrasound Med Biol; 2022 May; 48(5):730-742. PubMed ID: 35272892
[TBL] [Abstract][Full Text] [Related]
2. Performance of IOTA ADNEX model in evaluating adnexal masses in a gynecological oncology center in China.
Chen H; Qian L; Jiang M; Du Q; Yuan F; Feng W
Ultrasound Obstet Gynecol; 2019 Dec; 54(6):815-822. PubMed ID: 31152572
[TBL] [Abstract][Full Text] [Related]
3. Diagnostic Accuracies of the Ultrasound and Magnetic Resonance Imaging ADNEX Scoring Systems For Ovarian Adnexal Mass: Systematic Review and Meta-Analysis.
Cui L; Xu H; Zhang Y
Acad Radiol; 2022 Jun; 29(6):897-908. PubMed ID: 34217614
[TBL] [Abstract][Full Text] [Related]
4. Diagnostic Performance of Ultrasonography-Based Risk Models in Differentiating Between Benign and Malignant Ovarian Tumors in a US Cohort.
Yoeli-Bik R; Longman RE; Wroblewski K; Weigert M; Abramowicz JS; Lengyel E
JAMA Netw Open; 2023 Jul; 6(7):e2323289. PubMed ID: 37440228
[TBL] [Abstract][Full Text] [Related]
5. Performance of IOTA Simple Rules, Simple Rules risk assessment, ADNEX model and O-RADS in differentiating between benign and malignant adnexal lesions in North American women.
Hiett AK; Sonek JD; Guy M; Reid TJ
Ultrasound Obstet Gynecol; 2022 May; 59(5):668-676. PubMed ID: 34533862
[TBL] [Abstract][Full Text] [Related]
6. Estimating the risk of malignancy of adnexal masses: validation of the ADNEX model in the hands of nonexpert ultrasonographers in a gynaecological oncology centre in China.
He P; Wang JJ; Duan W; Song C; Yang Y; Wu QQ
J Ovarian Res; 2021 Dec; 14(1):169. PubMed ID: 34857005
[TBL] [Abstract][Full Text] [Related]
7. Preoperative Evaluation of the ADNEX Model for the Prediction of the Ovarian Cancer Risk of Adnexal Masses at Siriraj Hospital.
Poonyakanok V; Tanmahasamut P; Jaishuen A; Wongwananuruk T; Asumpinwong C; Panichyawat N; Chantrapanichkul P
Gynecol Obstet Invest; 2021; 86(1-2):132-138. PubMed ID: 33596584
[TBL] [Abstract][Full Text] [Related]
8. Subjective assessment and IOTA ADNEX model in evaluation of adnexal masses in patients with history of breast cancer.
Pozzati F; Sassu CM; Marini G; Mascilini F; Biscione A; Giannarelli D; Garganese G; Fragomeni SM; Scambia G; Testa AC; Moro F
Ultrasound Obstet Gynecol; 2023 Oct; 62(4):594-602. PubMed ID: 37204769
[TBL] [Abstract][Full Text] [Related]
9. Estimating risk of malignancy in adnexal masses: external validation of the ADNEX model and comparison with other frequently used ultrasound methods.
Meys EMJ; Jeelof LS; Achten NMJ; Slangen BFM; Lambrechts S; Kruitwagen RFPM; Van Gorp T
Ultrasound Obstet Gynecol; 2017 Jun; 49(6):784-792. PubMed ID: 27514486
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of the Diagnostic Value of the Ultrasound ADNEX Model for Benign and Malignant Ovarian Tumors.
Peng XS; Ma Y; Wang LL; Li HX; Zheng XL; Liu Y
Int J Gen Med; 2021; 14():5665-5673. PubMed ID: 34557021
[TBL] [Abstract][Full Text] [Related]
11. Diagnostic Accuracy of the ADNEX Model for Ovarian Cancer at the 15% Cut-Off Value: A Systematic Review and Meta-Analysis.
Huang X; Wang Z; Zhang M; Luo H
Front Oncol; 2021; 11():684257. PubMed ID: 34222006
[TBL] [Abstract][Full Text] [Related]
12. Performance of the IOTA ADNEX model combined with HE4 for identifying early-stage ovarian cancer.
Yang S; Tang J; Rong Y; Wang M; Long J; Chen C; Wang C
Front Oncol; 2022; 12():949766. PubMed ID: 36185223
[TBL] [Abstract][Full Text] [Related]
13. Two-Step Strategy for Optimizing the Preoperative Classification of Adnexal Masses in a University Hospital, Using International Ovarian Tumor Analysis Models: Simple Rules and Assessment of Different NEoplasias in the adneXa Model.
Esquivel Villabona AL; Rodríguez JN; Ayala N; Buriticá C; Gómez AC; Velandia AM; Rodríguez N; Alcázar JL
J Ultrasound Med; 2022 Feb; 41(2):471-482. PubMed ID: 33890698
[TBL] [Abstract][Full Text] [Related]
14. Performance of the IOTA ADNEX model in preoperative discrimination of adnexal masses in a gynecological oncology center.
Araujo KG; Jales RM; Pereira PN; Yoshida A; de Angelo Andrade L; Sarian LO; Derchain S
Ultrasound Obstet Gynecol; 2017 Jun; 49(6):778-783. PubMed ID: 27194129
[TBL] [Abstract][Full Text] [Related]
15. External Validation of the Assessment of Different NEoplasias in the adneXa Model Performance in Evaluating the Risk of Ovarian Carcinoma Before Surgery in China: A Tertiary Center Study.
Zhang Y; Zhao Y; Feng L
J Ultrasound Med; 2022 Sep; 41(9):2333-2342. PubMed ID: 34918371
[TBL] [Abstract][Full Text] [Related]
16. Evaluating the risk of ovarian cancer before surgery using the ADNEX model to differentiate between benign, borderline, early and advanced stage invasive, and secondary metastatic tumours: prospective multicentre diagnostic study.
Van Calster B; Van Hoorde K; Valentin L; Testa AC; Fischerova D; Van Holsbeke C; Savelli L; Franchi D; Epstein E; Kaijser J; Van Belle V; Czekierdowski A; Guerriero S; Fruscio R; Lanzani C; Scala F; Bourne T; Timmerman D;
BMJ; 2014 Oct; 349():g5920. PubMed ID: 25320247
[TBL] [Abstract][Full Text] [Related]
17. Contrast-enhanced ultrasonography in differential diagnosis of benign and malignant ovarian tumors.
Qiao JJ; Yu J; Yu Z; Li N; Song C; Li M
PLoS One; 2015; 10(3):e0118872. PubMed ID: 25764442
[TBL] [Abstract][Full Text] [Related]
18. Reliability of IOTA score and ADNEX model in the screening of ovarian malignancy in postmenopausal women.
Nohuz E; De Simone L; Chêne G
J Gynecol Obstet Hum Reprod; 2019 Feb; 48(2):103-107. PubMed ID: 29709594
[TBL] [Abstract][Full Text] [Related]
19. Diagnostic performance of contrast-enhanced ultrasound for ovarian cancer: a meta-analysis.
Wu Y; Peng H; Zhao X
Ultrasound Med Biol; 2015 Apr; 41(4):967-74. PubMed ID: 25701533
[TBL] [Abstract][Full Text] [Related]
20. Validation of IOTA-ADNEX Model in Discriminating Characteristics of Adnexal Masses: A Comparison with Subjective Assessment.
Jeong SY; Park BK; Lee YY; Kim TJ
J Clin Med; 2020 Jun; 9(6):. PubMed ID: 32604883
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
